These products are often referred to as compounded GLP-1 medications. SAHPRAs enforcement action On 23 May 2026, SAHPRA announced that it had intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing semaglutide, tirzepatide, or combination formulations
Generic Liraglutide: Available Now Generic liraglutide became available in 2024, offering patients an FDA-approved alternative in the same GLP-1 drug class as semaglutide
These statements have not been evaluated by the FDA.
Track Your Progress and Make Adjustments Tracking your meals, exercise, and symptoms such as hot flashes, GI disturbances, or energy levels can help you to understand how your nutrition and medications are impacting you during menopause
For tirzepatide users, constipation management , diarrhea duration , and fatigue follow similar patterns